Supportive Therapy for Adherence to ART(STAART) - Full Text View

Sponsors and Collaborators:	Ottawa Health Research Institute Ontario HIV Treatment Network
Information provided by:	Ottawa Health Research Institute
ClinicalTrials.gov Identifier:	NCT00212940

Purpose

The purpose of this study is to determine whether a psycho-educational intervention can help people living with HIV handle the changes of treatment adherence.

Condition	Intervention
HIV Infections	Behavioral: Supportive Therapy for Adherence to ART (behavior)

MedlinePlus related topics: AIDS

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title:	Increasing Patient Adherence to HIV Medications: A Prospective Intervention Study

Further study details as provided by Ottawa Health Research Institute:

Primary Outcome Measures:

psycho-educational intervention can help people living with HIV handle the changes of treatment adherence

Estimated Enrollment:	112
Study Start Date:	October 2000
Study Completion Date:	September 2006

Detailed Description:

Participants will be randomly assigned to one of two study groups:

Group 1: participants in this group will engage in weekly psycho-educational sessions with an HIV therapist for four weeks prior to starting their regimens. The sessions will cover topics such as becoming active in treatment care, improving coping abilities and developing skills for treatment adherence. They will also involve questionnaires and readings.
Group 2 (the control group):participants in this group will simply receive their regular treatment regimens.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

be at least 18 years of age
have viral load above 500 copies/ml
not be currently on HAART
be able to read and speak English/French

Exclusion Criteria:

current Substance Abuse
actively psychotic or suicidal

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00212940

Locations

Canada, Ontario
The Ottawa Hospital, General Campus
Ottawa, Ontario, Canada, K1H 8L6

Sponsors and Collaborators

Ottawa Health Research Institute

Ontario HIV Treatment Network

Investigators

Principal Investigator:

William Cameron, MD

OHRI

More Information

Study ID Numbers:	1999565-01H, CIHR app# 1262000 ICE:
Study First Received:	September 13, 2005
Last Updated:	July 25, 2007
ClinicalTrials.gov Identifier:	NCT00212940
Health Authority:	Canada: Health Canada

Keywords provided by Ottawa Health Research Institute:

Treatment Naive
HIV

Study placed in the following topic categories:

Virus Diseases
Sexually Transmitted Diseases, Viral
HIV Infections
Sexually Transmitted Diseases

Acquired Immunodeficiency Syndrome
Retroviridae Infections
Immunologic Deficiency Syndromes

Additional relevant MeSH terms:

RNA Virus Infections
Slow Virus Diseases
Immune System Diseases
Lentivirus Infections
Infection

ClinicalTrials.gov processed this record on January 14, 2009